Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Sr. VP of IP, CSO

President, CEO

SVP, Quality, GMP, Ops, IT

Senior Vice-President & CFO

SVP, Chief Medical Officer

Sr. V.P., Regulatory Affairs

Sr. VP, Chief Medical Officer

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and Oxtellar XR, an extended release oxcarbazepine for the monotherapy treatment of partial onset epilepsy seizures in adults and children between 6 to 17 years of age. The company's commercial products also comprise Qelbree, a novel non-stimulant indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in adults and pediatric patients 6 years and older; APOKYN for the acute intermittent treatment of hypomobility or off episodes in patients with advanced Parkinson's Disease (PD); XADAGO for treating levodopa/carbidopa in patients with PD experiencing off episodes; MYOBLOC, a Type B toxin product indicated for the treatment of cervical dystonia and sialorrhea in adults; GOCOVRI for the treatment of dyskinesia in patients with PD; and Osmolex ER for the treatment of Parkinson's disease and drug-induced extrapyramidal reaction in adult patients. In addition, its product candidates include SPN-830, a late-stage drug/device combination product candidate for the treatment of off episodes in PD patients; SPN-817, a novel product candidate in Phase I clinical trials for the treatment of severe epilepsy; and SPN-820, a product candidate in Phase II clinical trials for treating resistant depression. The company markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors. Supernus Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Rockville, Maryland.

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatmen...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-21	Premium	acquired	Premium	Premium	Premium	Sr. VP of IP, CSO
2024-03-21	Premium	sold	Premium	Premium	Premium	Sr. VP of IP, CSO
2024-03-20	Premium	sold	Premium	Premium	Premium	Sr. VP of IP, CSO
2024-03-20	Premium	acquired	Premium	Premium	Premium	Sr. VP of IP, CSO
2024-03-19	Premium	acquired	Premium	Premium	Premium	Sr. VP of IP, CSO
2024-03-19	Premium	sold	Premium	Premium	Premium	Sr. VP of IP, CSO
2024-03-13	Premium	acquired	Premium	Premium	Premium	Sr. VP of IP, CSO
2024-03-13	Premium	sold	Premium	Premium	Premium	Sr. VP of IP, CSO
2024-03-12	Premium	acquired	Premium	Premium	Premium	Sr. VP of IP, CSO
2024-03-12	Premium	sold	Premium	Premium	Premium	Sr. VP of IP, CSO
2024-02-28	Premium	sold (taxes)	Premium	Premium	Premium	President, CEO
2024-02-28	Premium	acquired	Premium	Premium	Premium	President, CEO
2024-02-28	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Quality, GMP, Ops, IT
2024-02-28	Premium	acquired	Premium	Premium	Premium	SVP, Quality, GMP, Ops, IT
2024-02-26	Premium	sold	Premium	Premium	Premium	Sr. VP of IP, CSO
2024-02-26	Premium	acquired	Premium	Premium	Premium	Sr. VP of IP, CSO
2024-02-23	Premium	acquired	Premium	Premium	Premium	-
2024-02-23	Premium	acquired	Premium	Premium	Premium	-
2024-02-23	Premium	acquired	Premium	Premium	Premium	-
2024-02-23	Premium	acquired	Premium	Premium	Premium	Sr. VP of IP, CSO
2024-02-23	Premium	acquired	Premium	Premium	Premium	Senior Vice-President & CFO
2024-02-23	Premium	acquired	Premium	Premium	Premium	SVP, Chief Medical Officer
2024-02-23	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Chief Medical Officer
2024-02-23	Premium	sold (taxes)	Premium	Premium	Premium	Sr. VP of IP, CSO
2024-02-23	Premium	sold (taxes)	Premium	Premium	Premium	Senior Vice-President & CFO

SUPN - Supernus Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for SUPN